The Journal of Organic Chemistry
Article
column chromatography eluting with petroleum ether/ethyl acetate
(5:1, v/v) gave 3 (66.4 mg, 75% yield) as a white solid: mp 246−248
°C; 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 7.5 Hz, 1H), 7.81 (s,
1H), 7.72−7.64 (m, 3H), 7.56 (s, 1H, br), 7.24 (d, J = 8.5 Hz, 1H),
7.07 (dd, J = 8.5, 2.5 Hz, 1H), 6.90 (d, J = 2.5 Hz, 1H), 6.87 (d, J =
8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 3.86 (s, 3H), 2.23 (s, 3H), 1.16
(s, 9H); 13C{1H} NMR (126 MHz, CDCl3) δ 176.9, 167.6, 167.5,
160.1, 138.6, 135.8, 134.4, 134.3, 132.6 131.7, 131.6 (2C), 130.4,
129.1, 127.2, 125.1, 124.1, 123.9, 123.9, 115.9, 114.6, 55.7, 39.6, 27.4,
21.5; DEPT-135 (126 MHz, CDCl3) δ 134.4 (upward), 134.3
(upward), 132.6 (upward), 129.1 (upward), 125.1 (upward), 124.1
(upward), 123.9 (upward), 123.9 (upward), 115.9 (upward), 114.6
(upward), 55.7 (upward), 27.4 (upward), 21.5 (upward); HRMS
(ESI-Q/TOF MS) with acetonitrile (m/z) [M + H]+ calcd for
C27H27N2O4 443.1965, found 443.1964.
129.1, 128.5, 127.1, 125.9, 124.0, 124.0, 122.4, 116.0, 114.9, 55.8,
39.7, 27.3; HRMS (ESI-Q/TOF MS) with acetonitrile (m/z) [M +
H]+ calcd for C26H24BrN2O4 507.0914, found 507.0915.
N-(2′-(1,3-Dioxoisoindolin-2-yl)-4′-methoxy-4-(trifluoromethyl)-
[1,1′-biphenyl]-2-yl)pivalamide (8). The reaction was performed
according to General Procedure 2A (20 equiv of CF3CO2H as the
only solvent) using amides 1g and 2a. Purification by flash column
chromatography eluting with petroleum ether/ethyl acetate (5:1, v/v)
1
gave 8 (43.7 mg, 44% yield) as a gray solid: mp 145−147 °C; H
NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.92−7.88 (m, 1H), 7.79−
7.69 (m, 4H), 7.28 (s, 1H), 7.20 (dd, J = 8.0, 1.2 Hz, 1H), 7.14 (dd, J
= 8.4, 2.4 Hz, 2H), 6.97 (d, J = 2.4 Hz, 1H), 3.92 (s, 3H), 1.20 (s,
9H); 13C{1H} NMR (101 MHz, CDCl3) δ 177.1, 167.5 (2C), 160.7,
2
136.9, 134.7, 134.6, 133.0, 132.0, 131.7, 131.6, 131.1 (C−F, JC−F
=
=
1
32.6 Hz), 130.0, 128.9, 124.5, 124.1, 124.1, 123.9 (C−F, JC−F
3
3
272.6 Hz), 120.6 (C−F, JC−F = 4.0 Hz), 120.0 (C−F, JC−F = 4.0
Hz), 116.2, 115.0, 55.8, 39.8, 27.4; 19F NMR (376 MHz, CDCl3) δ
−62.7; HRMS (ESI-Q/TOF MS) with acetonitrile (m/z) [M + H]+
calcd for C27H24F3N2O4 497.1683, found 497.1683.
N-(2′-(1,3-Dioxoisoindolin-2-yl)-4-ethyl-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (4). The reaction was performed according
to General Procedure 2A using amides 1b and 2a. Purification by flash
column chromatography eluting with petroleum ether/ethyl acetate
(4:1, v/v) gave 4 (73 mg, 80% yield) as a white solid: mp 183−185
N-(2′-(1,3-Dioxoisoindolin-2-yl)-5-ethyl-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (9). The reaction was performed according
to General Procedure 2A using amides 1h and 2a. Purification by flash
column chromatography eluting with petroleum ether/ethyl acetate
(4:1, v/v) gave 9 (59.3 mg, 65% yield) as a white solid: mp 154−156
°C; 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.6 Hz, 1H), 7.82 (d,
J = 8.4 Hz, 1H), 7.76−7.62 (m, 3H), 7.52 (s, 1H, br), 7.30 (d, J = 8.8
Hz, 1H), 7.10 (dd, J = 8.4, 2.4 Hz, 1H), 7.01 (d, J = 8.4 Hz, 1H), 6.94
(d, J = 2.4 Hz, 1H), 6.83 (s, 1H), 3.89 (s, 3H), 2.48−2.31 (m, 2H),
1.18 (s, 9H), 0.91 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (101 MHz,
CDCl3) δ 176.8, 167.6, 167.6, 160.1, 140.3, 134.4, 134.3, 133.5, 132.1,
131.7, 131.7, 131.6, 130.6, 130.2, 128.5, 128.2, 123.9, 123.7, 123.7,
115.8, 114.7, 55.7, 39.5, 28.2, 27.4, 15.6; HRMS (ESI-Q/TOF MS)
with acetonitrile (m/z) [M + H]+ calcd for C28H29N2O4 457.2122,
found 457.2124.
1
°C; H NMR (400 MHz, CDCl3) δ 7.92−7.82 (m, 2H), 7.78−7.64
(m, 3H), 7.59 (s, 1H, br), 7.27 (d, J = 8.8 Hz, 1H), 7.09 (dd, J = 8.8,
2.4 Hz, 1H), 6.96−6.88 (m, 2H), 6.77 (d, J = 7.6 Hz, 1H), 3.88 (s,
3H), 2.55 (q, J = 7.6 Hz, 2H), 1.18 (s, 9H), 1.15 (t, J = 7.6 Hz, 3H);
13C{1H} NMR (101 MHz, CDCl3) δ 176.8, 167.6, 167.4, 160.1,
144.8, 135.8, 134.4, 134.3, 132.5, 131.7, 131.7, 131.5, 130.4, 129.2,
127.3, 123.8 (2C), 123.7, 122.8, 115.8, 114.6, 55.7, 39.6, 28.8, 27.4,
15.2; HRMS (ESI-Q/TOF MS) with acetonitrile (m/z) [M + H]+
calcd for C28H29N2O4 457.2122, found 457.2122.
N-(2′-(1,3-Dioxoisoindolin-2-yl)-4-fluoro-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (5). The reaction was performed according
to General Procedure 2A using amides 1d and 2a. Purification by flash
column chromatography eluting with petroleum ether/ethyl acetate
(5:1, v/v) gave 5 (75 mg, 84% yield) as a white solid: mp 173−175
1
°C; H NMR (400 MHz, CDCl3) δ 7.89 (dd, J = 11.2, 2.8 Hz, 1H),
N-(5-Chloro-2′-(1,3-dioxoisoindolin-2-yl)-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (10). The reaction was performed according
to General Procedure 2A (5 mol % of Pd(OAc)2) using amides 1i and
2a. Purification by flash column chromatography eluting with
petroleum ether/ethyl acetate (5:1, v/v) gave 10 (38.9 mg, 42%
yield) as a white solid: mp 165−166 °C; 1H NMR (400 MHz,
CDCl3) δ 7.95−7.85 (m, 2H), 7.80−7.65 (m, 1H), 7.59 (s, 1H, br),
7.23 (d, J = 8.8 Hz, 1H), 7.17 (dd, J = 8.8, 2.4 Hz, 1H), 7.08 (dd, J =
8.8, 2.4 Hz, 1H), 7.00 (d, J = 2.4 Hz, 1H), 6.91 (d, J = 2.8 Hz, 1H),
3.87 (s, 3H), 1.15 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3) δ
177.0, 167.6, 167.4, 160.6, 134.9, 134.7, 134.5, 132.2, 131.8, 131.6,
131.6, 131.5, 129.3, 129.2, 129.0, 128.8, 124.8, 124.1, 123.9, 116.0,
114.8, 55.8, 39.7, 27.4; HRMS (ESI-Q/TOF MS) with acetonitrile
(m/z) [M + H]+ calcd for C26H24ClN2O4 463.1419, found 463.1422.
N-(5-Bromo-2′-(1,3-dioxoisoindolin-2-yl)-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (11). The reaction was performed according
to General Procedure 2A (5 mol % of Pd(OAc)2) using amides 1j and
2a. Purification by flash column chromatography eluting with
petroleum ether/ethyl acetate (5:1, v/v) gave 11 (46.7 mg, 46%
yield) as a white solid: mp 150−152 °C; 1H NMR (400 MHz,
CDCl3) δ 7.94−7.83 (m, 2H), 7.76−7.65 (m, 3H), 7.57 (s, 1H, br),
7.31 (dd, J = 8.8, 2.4 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H), 7.15 (d, J =
2.0 Hz, 1H), 7.08 (dd, J = 8.4, 2.4 Hz, 1H), 6.91 (d, J = 2.4 Hz, 1H),
3.87 (s, 3H), 1.14 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3) δ
176.9, 167.6, 167.3, 160.6, 135.4, 134.7, 134.5, 132.1 (2C), 132.0,
131.7, 131.7, 131.6, 128.9, 124.9, 124.9, 124.1, 123.9, 116.8, 116.0,
114.9, 55.8, 39.7, 27.4; HRMS (ESI-Q/TOF MS) with acetonitrile
(m/z) [M + H]+ calcd for C26H24BrN2O4 507.0914, found 507.0915.
N-(2′-(1,3-Dioxoisoindolin-2-yl)-4′-methoxy-5-(trifluoromethyl)-
[1,1′-biphenyl]-2-yl)pivalamide (12). The reaction was performed
according to General Procedure 2A (5 mol % of Pd(OAc)2) using
amides 1k and 2a. Purification by flash column chromatography
eluting with petroleum ether/ethyl acetate (4:1, v/v) gave 12 (37.7
mg, 38% yield) as a gray solid: mp 115−116 °C; 1H NMR (500 MHz,
CDCl3) δ 8.25 (d, J = 8.5 Hz, 1H), 7.87 (d, J = 7.5 Hz, 1H), 7.75−
7.64 (m, 4H), 7.45 (dd, J = 8.5, 2.0 Hz, 1H), 7.31−7.26 (m, 2H), 7.13
7.86−7.82 (m, 1H), 7.74−7.65 (m, 3H), 7.58 (s, 1H, br), 7.24 (d, J =
8.8 Hz, 1H), 7.09 (dd, J = 8.8, 2.4 Hz, 1H), 6.95 (dd, J = 8.4, 6.4 Hz,
1H), 6.92 (d, J = 2.4 Hz, 1H), 6.61 (td, J = 8.4, 2.8 Hz, 1H), 3.87 (s,
3H), 1.15 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3) δ 176.8, 167.5,
1
3
167.3, 162.5 (C−F, JC−F = 245.2 Hz), 160.4, 137.6 (C−F, JC−F
=
=
3
11.8 Hz), 134.6, 134.5, 132.5, 132.1, 131.6, 131.4 130.5 (d, JC−F
4
9.4 Hz), 129.2, 124.9 (C−F, JC−F = 3.1 Hz), 123.9, 123.9, 116.0,
114.9, 110.8 (C−F, 2JC−F = 21.8 Hz), 109.9 (C−F, 2JC−F = 26.7 Hz),
55.7, 39.8, 27.3; 19F NMR (376 MHz, CDCl3) δ −111.7; HRMS
(ESI-Q/TOF MS) with acetonitrile (m/z) [M + H]+ calcd for
C26H24FN2O4 447.1715, found 447.1714.
N-(4-Chloro-2′-(1,3-dioxoisoindolin-2-yl)-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (6). The reaction was performed according
to General Procedure 2A using amides 1e and 2a. Purification by flash
column chromatography eluting with petroleum ether/ethyl acetate
(5:1, v/v) gave 6 (78.7 mg, 85% yield) as a white solid: mp 197−199
1
°C; H NMR (400 MHz, CDCl3) δ 8.12 (d, J = 2.0 Hz, 1H), 7.89−
7.82 (m, 1H), 7.79−7.66 (m, 3H), 7.58 (s, 1H, br), 7.23 (d, J = 8.8
Hz, 1H), 7.09 (dd, J = 8.8, 2.8 Hz, 1H), 6.96−6.85 (m, 3H), 3.87 (s,
3H), 1.15 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3) δ 176.9, 167.5,
167.4, 160.5, 137.2, 134.6, 134.5, 134.3, 132.2, 131.8, 131.6, 131.4,
130.3, 129.1, 127.9, 124.1, 124.0, 123.9, 123.0, 116.0, 114.9, 55.8,
39.7, 27.3; HRMS (ESI-Q/TOF MS) with acetonitrile (m/z) [M +
H]+ calcd for C26H24ClN2O4 463.1419, found 463.1418.
N-(4-Bromo-2′-(1,3-dioxoisoindolin-2-yl)-4′-methoxy-[1,1′-bi-
phenyl]-2-yl)pivalamide (7). The reaction was performed according
to General Procedure 2A using amides 1f and 2a. Purification by flash
column chromatography eluting with petroleum ether/ethyl acetate
(5:1, v/v) gave 7 (75.1 mg, 74% yield) a white solid: mp 194−196
1
°C; H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 2.0 Hz, 1H), 7.89−
7.82 (m, 1H), 7.78−7.65 (m, 3H), 7.57 (s, 1H, br), 7.23 (d, J = 8.4
Hz, 1H), 7.09 (dd, J = 8.4, 2.4 Hz, 1H), 7.04 (dd, J = 8.4, 2.0 Hz,
1H), 6.91 (d, J = 2.4 Hz, 1H), 6.86 (d, J = 8.4 Hz, 1H), 3.86 (s, 3H),
1.15 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3) δ 176.8, 167.4,
167.4, 160.5, 137.4, 134.6, 134.5, 132.2, 131.7, 131.6, 131.4, 130.6,
2724
J. Org. Chem. 2021, 86, 2714−2733